HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity

Molecular and Cellular Biology

Volumn 23, Issue 7, 2003, Pages 2329-2340

  Bouallaga, Isabelle ^a   Teissier, Sébastien ^a   Yaniv, Moshe ^a   Thierry, Françoise ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCEOSOME; HIGH MOBILITY GROUP B1 PROTEIN; NUCLEOPROTEIN; PROTEIN P300; TRANSCRIPTION FACTOR FRA 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; BINDING SITE; CHROMATIN; COMPLEX FORMATION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; VIRUS TRANSCRIPTION; WART VIRUS;

ADENOVIRUS E1A PROTEINS; BASE SEQUENCE; CELL NUCLEUS; DNA FOOTPRINTING; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); FOS-RELATED ANTIGEN-2; HELA CELLS; HMGA1A PROTEIN; HUMANS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; NUCLEOPROTEINS; PAPILLOMAVIRIDAE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ADENOVIRIDAE; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; RNA VIRUSES;

EID: 0037377734     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.7.2329-2340.2003     Document Type: Article

References (56)

1. Agalioti, T., S. Lomvardas, B. Parekh, J. Yie, T. Maniatis, and D. Thanos. 2000. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103:667-678.
2. Ait-Si-Ali, S., A. Polesskaya, S. Filleur, R. Ferreira, A. Duquet, P. Robin, A. Vervish, D. Trouche, F. Cabon, and A. Harel-Bellan. 2000. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene 19:2430-2437.
3. Angel, P., I. Baumann, B. Stein, H. Delius, H. J. Rahmsdorf, and P. Herrlich. 1987. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7:2256-2266.
4. Arends, M. J., Y. K. Donaldson, E. Duvall, A. H. Wyllie, and C. C. Bird. 1993. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16. Hum. Pathol. 24:432-437.
5. Arias, J., A. S. Alberts, P. Brindle, F. X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-229.
6. Bagga, R., S. Michalowski, R. Sabnis, J. D. Griffith, and B. M. Emerson. 2000. HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology. Nucleic Acids Res. 28:2541-2550.
7. Bakiri, L., K. Matsuo, M. Wisniewska, E. F. Wagner, and M. Yaniv. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22:4952-4964.
8. Bandiera, A., D. Bonifacio, G. Manfioletti, F. Mantovani, A. Rustighi, F. Zanconati, A. Fusco, L. Di Bonito, and V. Giancotti. 1998. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 58:426-431.
9. Bannister, A. J., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
10. Bednarek, P. H., B. J. Lee, S. Gandhi, E. Lee, and B. Phillips. 1998. Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting. J. Virol. 72:708-716.
11. Bouallaga, I., S. Massicard, M. Yaniv, and F. Thierry. 2000. An enhanceosome containing the JunB/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV18 transcription. EMBO Rep. 1:422-427.
12. Butz, K., and F. Hoppe-Seyler. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67:6476-6486.
13. Carey, M. 1998. The enhanceosome and transcriptional synergy. Cell 92:5-8.
14. Chau, K. Y., N. Munshi, A. Keane-Myers, K. W. Cheung-Chau, A. K. Tai, G. Manfioletti, C. K. Dorey, D. Thanos, D. J. Zack, and S. J. Ono. 2000. The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression. J. Neurosci. 20:7317-7324.
15. Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, and R. M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
16. Desaintes, C., C. Demeret, S. Goyat, M. Yaniv, and F. Thierry. 1997. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16:504-514.
17. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
18. Foster, L. C., P. Wiesel, G. S. Huggins, R. Panares, M. T. Chin, A. Pellacani, and M. A. Perrella. 2000. Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. FASEB J. 14:368-378.
19. French, S. W., M. C. Schmidt, and J. C. Glorioso. 1996. Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2. Mol. Cell. Biol. 16:5393-5399.
20. Garcia-Carranca, A., F. Thierry, and M. Yaniv. 1988. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J. Virol. 62:4321-4330.
21. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995-1008.
22. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
23. Henderson, A., M. Bunce, N. Siddon, R. Reeves, and D. J. Tremethick. 2000. High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter. J. Virol. 74:10523-10534.
24. Janknecht, R., and T. Hunter. 1996. Transcription. A growing coactivator network. Nature 383:22-23.
25. John, S., R. B. Reeves, J. X. Lin, R. Child, J. M. Leiden, C. B. Thompson, and W. J. Leonard. 1995. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol. Cell. Biol. 15:1786-1796.
26. Kannabiran, C., G. F. Morris, C. Labrie, and M. B. Mathews. 1993. The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter. J. Virol. 67:507-515.
27. Kim, T. K., T. H. Kim, and T. Maniatis. 1998. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro. Proc. Natl. Acad. Sci. USA 95:12191-12196.
28. Klein-Hessling, S., G. Schneider, A. Heinfling, S. Chuvpilo, and E. Serfling. 1996. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells. Proc. Natl. Acad. Sci. USA 93:15311-15316.
29. Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bachinger, R. G. Brennan, S. G. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226.
30. Lee, J. S., R. H. See, T. Deng, and Y. Shi. 1996. Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol. 16:4312-4326.
31. Leger, H., E. Sock, K. Renner, F. Grummt, and M. Wegner. 1995. Functional interaction between the POU domain protein Tst-1/Oct-6 and the highmobility-group protein HMG-I/Y. Mol. Cell. Biol. 15:3738-3747.
32. Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85-88.
33. Mack, D. H., and L. A. Laimins. 1991. A keratinocyte-specific transcription factor, KRF-1, interacts with AP1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc. Natl. Acad. Sci. USA 88:9102-9106.
34. Maher, J. F., and D. Nathans. 1996. Multivalent DNA-binding properties of the HMG-1 proteins. Proc. Natl. Acad. Sci. USA 93:6716-6720.
35. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14:1156-1166.
36. Merika, M., A. J. Williams, G. Chen, T. Collins, and D. Thanos. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1:277-287.
37. Munshi, N., T. Agalioti, S. Lomvardas, M. Merika, G. Chen, and D. Thanos. 2001. Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293:1133-1136.
38. O'Connor, M., S. Chan, and H. U. Bernard. 1995. Transcription factor binding sites in the long control region of genital HPVs, p. 21-40. In G. Myers, H. U. Bernard, H. Delius, K. Baker, J. Icenogle, A. Halpern, and C. Wheeler (ed.), Human papillomaviruses, 1995 compendium, part III. Los Alamos National Laboratory, Los Alamos, N. Mex.
39. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
40. Panagiotidis, C. A., and S. J. Silverstein. 1999. The host-cell architectural protein HMG I(Y) modulates binding of herpes simplex virus type 1 ICP4 to its cognate promoter. Virology 256:64-74.
41. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
42. Reeves, R., D. D. Edberg, and Y. Li. 2001. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21:575-594.
43. Reeves, R., and M. S. Nissen. 1990. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J. Biol. Chem. 265:8573-8582.
44. Romanczuk, H., L. L. Villa, R. Schlegel, and P. M. Howley. 1991. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 65:2739-2744.
45. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
46. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
47. Shi, Y., E. Seto, L. S. Chang, and T. Shenk. 1991. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67:377-388.
48. Spencer, T. E., G. Jenster, M. M. Burcin, C. D. Allis, J. Zhou, C. A. Mizzen, N. J. McKenna, S. A. Onate, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198.
49. Stein, R. W., M. Corrigan, P. Yaciuk, J. Whelan, and E. Moran. 1990. Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J. Virol. 64:4421-4427.
50. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 71:777-789.
51. Thierry, F., G. Spyrou, M. Yaniv, and P. M. Howley. 1992. Two AP1 sites binding JunB are essential for HPV18 transcription in keratinocytes. J. Virol. 66:3740-3748.
52. Werner, M. H., and S. K. Burley. 1997. Architectural transcription factors: proteins that remodel DNA. Cell 88:733-736.
53. Whitley, M. Z., D. Thanos, M. A. Read, T. Maniatis, and T. Collins. 1994. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol. Cell. Biol. 14:6464-6475.
54. Wood, L. J., J. F. Maher, T. E. Bunton, and L. M. Resar. 2000. The oncogenic properties of the HMG-I gene family. Cancer Res. 60: 4256-4261.
55. Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324.
56. Yie, J., M. Merika, N. Munshi, G. Chen, and D. Thanos. 1999. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J. 18:3074-3089.